Mark D. Rosen - Concepedia

Author

Mark D. Rosen

Johnson & Johnson (United States)

Also Known As

Mark D Rosen, Mark D. Rosen, Mark Rosen

Publications

771

Citations

H-Index

Concepts

All Affiliations

Johnson & Johnson (United States)Janssen (United States)University of California, Irvine Universitat Pompeu Fabra Pontificia Universidad Católica de Chile

About

Mark D. Rosen is an author at Johnson & Johnson (United States) specializing in natural sciences, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	5	5	278
2	Medicine	4	4	170
3	Biochemistry	4	4	238
4	Engineering	2	2	141
5	Social Sciences	1	1	33

Mark D. Rosen

Publications

689

Citations

H-Index

Page 1

	Year	Citations
Total Synthesis of (−)-Spirotryprostatin B and Three Stereoisomers Larry E. Overman, Mark D. Rosen Angewandte Chemie International Edition	2000	166
Total Synthesis of (±)-Didehydrostemofoline (Asparagamine A) and (±)-Isodidehydrostemofoline Markus Brüggemann, Andrew I. McDonald, Larry E. Overman, Journal of the American Chemical Society Bioorganic ChemistryEngineeringBiochemistryHeterocyclicNatural Sciences	2003	97
Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter, Molecular Pharmacology	2011	72
Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues Mark D. Rosen, Hariharan Venkatesan, Hillary M. Peltier, ACS Medicinal Chemistry Letters Erythropoietin SecretionPharmacotherapyRedox BiologyOxidative StressSystems Pharmacology	2010	62
Terminating catalytic asymmetric Heck cyclizations by stereoselective intramolecular capture of η3-allylpalladium intermediates: total synthesis of (−)-spirotryprostatin B and three stereoisomers Larry E. Overman, Mark D. Rosen Tetrahedron -Spirotryprostatin BEngineeringBiochemistryNatural SciencesTotal Synthesis	2010	44
Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation‐induced anaemia in rats Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter, British Journal of Pharmacology	2015	43
Discovery of the first known small-molecule inhibitors of heme-regulated eukaryotic initiation factor 2α (HRI) kinase Mark D. Rosen, Craig R. Woods, Steven D. Goldberg, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyNatural SciencesMolecular BiologyHeme SignalingSmall-molecule Inhibitors	2009	40
Identification and Optimization of Anthranilic Sulfonamides as Novel, Selective Cholecystokinin-2 Receptor Antagonists Brett D. Allison, Victor K. Phuong, Laura C. McAtee, Journal of Medicinal Chemistry Medicinal ChemistryDrug TargetPharmaceutical Science1000-Fold SelectivityBiochemistry	2006	35
Consolidation of object recognition memory requires HRI kinase‐dependent phosphorylation of eIF2α in the hippocampus Gerard ILL‐Raga, Cristiano A. Köhler, Andressa Radiske, Hippocampus Nitric OxideSynaptic TransmissionNeurotransmissionSynaptic SignalingSocial Sciences	2013	33
Physiological Control of Nitric Oxide in Neuronal <i>BACE1</i> Translation by Heme-Regulated eIF2α Kinase HRI Induces Synaptogenesis Gerard ILL‐Raga, Marta Tajes, Arnau Busquets-García, Antioxidants and Redox Signaling	2015	33

Page 1